Boehringer Ingelheim, MD Anderson to develop cancer drugs under research partnership

0
30


The two organizations are placing particular emphasis on lung and gastrointestinal cancers, as well as drug targets like KRAS mutations.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here